The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis.

[1]  R. Medzhitov,et al.  Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88 , 2007, Science.

[2]  Ravi S. Misra,et al.  Caspase-8 and c-FLIPL Associate in Lipid Rafts with NF-κB Adaptors during T Cell Activation* , 2007, Journal of Biological Chemistry.

[3]  G. Stamp,et al.  Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice , 2007, Cell.

[4]  Y. You,et al.  CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-κB activation , 2007 .

[5]  Gabriella De Vita,et al.  p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis , 2007 .

[6]  W. Yeh,et al.  An antiapoptotic protein, c‐FLIPL, directly binds to MKK7 and inhibits the JNK pathway , 2006, The EMBO journal.

[7]  M. Diaz-Meco,et al.  Cell signaling and function organized by PB1 domain interactions. , 2006, Molecular cell.

[8]  Pilar Martín,et al.  The signaling adapter p62 is an important mediator of T helper 2 cell function and allergic airway inflammation , 2006, The EMBO journal.

[9]  M. Karin.  Nuclear factor-κB in cancer development and progression , 2006, Nature.

[10]  K. Okumura,et al.  Reactive oxygen species mediate crosstalk between NF-κB and JNK , 2006, Cell Death and Differentiation.

[11]  Gabriel Pineda,et al.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.

[12]  Paul A. Khavari,et al.  Modelling cancer in human skin tissue , 2006, Nature Reviews Cancer.

[13]  M. Karin,et al.  The E3 Ubiquitin Ligase Itch Couples JNK Activation to TNFα-induced Cell Death by Inducing c-FLIPL Turnover , 2006, Cell.

[14]  Michael Karin,et al.  IKK/NF-κB signaling: balancing life and death – a new approach to cancer therapy , 2005 .

[15]  M. Diaz-Meco,et al.  The p62 Scaffold Regulates Nerve Growth Factor-induced NF-κB Activation by Influencing TRAF6 Polyubiquitination* , 2005, Journal of Biological Chemistry.

[16]  Zhijian J. Chen.  Ubiquitin signalling in the NF-κB pathway , 2005, Nature Cell Biology.

[17]  Michael Karin,et al.  IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.

[18]  Michael Karin,et al.  Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.

[19]  L. Salmena,et al.  Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor , 2005, Science.

[20]  R. Flavell,et al.  JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. , 2004, Genes & development.

[21]  Francesca Zazzeroni,et al.  Ferritin Heavy Chain Upregulation by NF-κB Inhibits TNFα-Induced Apoptosis by Suppressing Reactive Oxygen Species , 2004, Cell.

[22]  Michael Karin,et al.  IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer , 2004, Cell.

[23]  R. DePinho,et al.  Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. , 2004, Cancer cell.

[24]  Manuel Serrano,et al.  The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. , 2004, Developmental cell.

[25]  Honglin Zhou,et al.  Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.

[26]  Manuel Serrano,et al.  Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. , 2003, Cancer cell.

[27]  M. Barbacid,et al.  RAS oncogenes: the first 30 years , 2003, Nature Reviews Cancer.

[28]  D. Bar-Sagi,et al.  Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. , 2003, Genes & development.

[29]  M. Serrano,et al.  Genetic inactivation of Par4 results in hyperactivation of NF‐κB and impairment of JNK and p38 , 2003, EMBO reports.

[30]  M. Karin,et al.  Missing Pieces in the NF-κB Puzzle , 2002, Cell.

[31]  H. Varmus,et al.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.

[32]  M. Karin,et al.  Inhibition of JNK activation through NF-κB target genes , 2001, Nature.

[33]  Francesca Zazzeroni,et al.  Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling , 2001, Nature.

[34]  Juan F. García,et al.  Targeted Disruption of the ζPKC Gene Results in the Impairment of the NF-κB Pathway , 2001 .

[35]  Marty W. Mayo,et al.  Akt Stimulates the Transactivation Potential of the RelA/p65 Subunit of NF-κB through Utilization of the IκB Kinase and Activation of the Mitogen-activated Protein Kinase p38* , 2001, The Journal of Biological Chemistry.

[36]  M. Diaz-Meco,et al.  The atypical protein kinase Cs , 2000, EMBO reports.

[37]  S. Thorgeirsson,et al.  Role of the IκB Kinase Complex in Oncogenic Ras- and Raf-Mediated Transformation of Rat Liver Epithelial Cells , 2000, Molecular and Cellular Biology.

[38]  H. Nakano,et al.  The atypical PKC‐interacting protein p62 channels NF‐κB activation by the IL‐1–TRAF6 pathway , 2000, The EMBO journal.

[39]  M. Serrano,et al.  The downregulation of the pro‐apoptotic protein Par‐4 is critical for Ras‐induced survival and tumor progression , 1999, The EMBO journal.

[40]  H. Sakurai,et al.  IκB Kinases Phosphorylate NF-κB p65 Subunit on Serine 536 in the Transactivation Domain* , 1999, The Journal of Biological Chemistry.

[41]  M. Diaz-Meco,et al.  The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation , 1999, The EMBO journal.

[42]  G. Bren,et al.  Activation of IκB Kinase β by Protein Kinase C Isoforms , 1999, Molecular and Cellular Biology.

[43]  C. Der,et al.  Oncogenic Ha-Ras-induced Signaling Activates NF-κB Transcriptional Activity, Which Is Required for Cellular Transformation* , 1997, The Journal of Biological Chemistry.

[44]  L. Sanz,et al.  Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. , 1994, The Journal of biological chemistry.

[45]  A. Malkinson.  Promoters, co-carcinogens and inhibitors of pulmonary carcinogenesis in mice: an overview. , 1991, Experimental lung research.

[46]  Joyce Bos.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[47]  J. Downward.  Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[48]  M. Mayo,et al.  Ras regulation of NF-KB and apoptosis , 2001 .